3 results match your criteria: "Centre Anti-Poisons du Maroc[Affiliation]"
Int J Clin Pharmacol Ther
December 2002
Laboratoire de Toxicologie d'Urgence et de Suivi Thérapeutique, Centre Anti-Poisons du Maroc, Institut National d'Hygiène, Rabat, Maroc.
A large interindividual variability in drug acetylation is associated with genetic polymorphism of the polymorphic Type 2 N-acetyltransferase (NAT2), and an important interethnic difference has been frequently observed. However, few data on this polymorphism in the Moroccan population are available. In the present study the acetylator phenotype in 89 Moroccan patients with tuberculosis has been determined using isoniazid (INH) as metabolic probe.
View Article and Find Full Text PDFJ Chromatogr B Analyt Technol Biomed Life Sci
January 2002
Laboratoire de Toxicologie d'Urgence et de Suivi Thérapeutique, Centre Anti-Poisons du Maroc, Institut National d'Hygiène, Rabat.
Simultaneous measurement of isoniazid and its main acetylated metabolite acetylisoniazid in human plasma is realized by high-performance liquid chromatography. The technique used is evaluated by a factorial design of validation that proved to be convenient for routine drug monitoring. Plasma samples are deproteinized by trichloroacetic acid and then the analytes are separated on a microBondapak C18 column (Waters).
View Article and Find Full Text PDFPresse Med
November 1997
Centre Anti-Poisons du Maroc et de Pharmacovigilance, Rabat, Maroc.
Objectives: No current data is available on plumbism in Morocco. We conducted this work to evaluate blood lead levels in inhabitants of the Rabat region.
Patients And Methods: The study included 385 subjects, 300 men and 85 women, age range 18-55 years, who were volunteer blood donors at the Rabat blood bank.